Welcome to the WCN 2021 Interactive Program
The congress will officially run on Central European Time (CET) - Rome Time
To convert the congress times to your local time Click Here
Please note that all sessions will run at their scheduled time and be followed by a LIVE Q&A/Discussion at the end
The viewing of sessions, cannot be accessed from this conference calendar. All sessions are accessible via the Virtual Platform
- Laura P. Obici (Italy)
Please join us for the Pfizer-sponsored industry symposium “A deep dive into transthyretin amyloidosis (ATTR): from pathophysiology to treatment of a multisystemic disease”.
During this symposium, our expert faculty will discuss the systemic nature of ATTR amyloidosis and subsequent need for a multidisciplinary team. They will highlight the available treatment options for ATTR amyloidosis, with supporting clinical and real-world evidence and will discuss a multidisciplinary approach to disease management. The symposium will also feature a clinical case study presented from expert neurology and cardiology perspectives. We hope you can join for what promises to be an informative and educational session.
A deep dive into transthyretin amyloidosis (ATTR): from pathophysiology to treatment of a multisystemic disease
Supported by Pfizer
Welcome and introduction
- Laura P. Obici (Italy)
Foundations in ATTR amyloidosis: an overview of a multisystemic disease
- Laura P. Obici (Italy)
Targeted treatment for ATTR amyloidosis: clinical and real-world evidence
- Fabio Barroso (Argentina)
Multidisciplinary care of patients with ATTR amyloidosis: a practical approach
- Anna Mazzeo (Italy)
- Ruxandra Jurcut
Q&A, followed by closing remarks
- Laura P. Obici (Italy)